The Emily Whitehead Foundation has been at the center of the biotech community this week in Philadelphia, with two impactful events supporting their mission to help families, children and researchers activate the cure for childhood cancer and access new CART-T therapies.
(Image generated by AI) Biotech Industry Leaders Share Why Companies Should Remain Focused on Talent By Chris FrewMay 24, 2023 At last week’s BioBuzz annual Awards Celebration and Symposium, talent [….]
Upcoming 3rd Annual BioBuzz Awards to Celebrate Winners from Maryland, Philadelphia In addition to the reception, the event will also feature several panels comprised of esteemed local key opinion leaders [….]
Give Me Some Space! The Latest on Life Science Lab Spaces in Greater Philadelphia By Mark TerryApril 25, 2023 This section sponsored by ECBuild / EwingCole According to the Winter 2023 Philadelphia Life [….]
King of Prussia, Pa.-based Center for Breakthrough Medicines (CBM), a contract development, manufacturing, and testing organization (CDMO) has had the “pedal to the metal” this year with a range of strategic partnerships. The company’s Co-founder and Chief Business Officer, Aubrey Greenberg, spoke with BioBuzz about the company’s activities and strategy moving forward.
This buzzing hive of life sciences innovation, as it grows, will require not only funding and talent, but also the development and manufacturing support to advance pipelines into the clinic and beyond. While many large, established pharma and biotech companies have the means to add in-house lab space and advanced biomanufacturing capabilities, most young and emerging organizations do not. And some large companies see building in-house facilities as too expensive and risky.
Here’s the latest life science news happening out of Greater Philly
In its quest to be one of the top Contract Development and Manufacturing Organizations in the world, the Center for Breakthrough Medicines (CBM) will implement a robust digital solutions system that will support end-to-end cell and gene therapy manufacturing processes.
Today, we are excited to announce the winners of our 3rd Annual BioBuzz Awards. The BioBuzz Awards are a celebration of the exciting and groundbreaking work being done by the BioHealth Capital Region (BHCR) and Greater Philadelphia life science communities and the individuals that make innovation happen.
King of Prussia, PA — December 08, 2022 —The Center for Breakthrough Medicines (CBM), a contract development, manufacturing, and testing organization (CDMO) has launched Genesis Vector Manufacturing SolutionsTM to help innovator companies reimagine vector manufacturing by simplifying the value chain and accelerate their path to clinic and commercial launch.
CBM’s Genesis Vector Manufacturing SolutionsTM is an end-to-end offering that includes plasmid manufacturing, first-time right process development and high-throughput GMP vector manufacturing suites to accelerate development and manufacturing timelines. Integrated testing & analytics, supply chain, and regulatory services co-located with manufacturing at a single site drastically simplifies the vector value chain. CBM’s new, purpose-built facility is engineered and outfitted to support a wide variety of vectors, including viral-based products (such as those used for gene-modified cell therapies in CBM’s previously announced expansion) as well as other novel biologically derived delivery vectors compliant with the most robust segregation controls.
“This past year has been a catalyst moment for gene therapies with approvals and authorizations doubling the number of treatments available, accelerating the need for high throughput manufacturing of diverse vectors used to deliver lifesaving therapies,” said Audrey Greenberg, CBM’s Co-founder and Chief Business Officer. “We are thrilled to complete phase one of…
